Depression and Anxiety Disorders Impact in the Quality of Life of Patients with Inflammatory Bowel Disease
Table 1
Demographic and clinical features between IBD patients with and without depression or anxiety disorder.
(a)
Depression present ()
Anxiety present ()
(%)
95% C.I.
value
(%)
95% C.I.
value
Gender-female
10 (40.0)
0.6-3.8
0.35
15 (71.4)
0.1-0.8
0.01
Occupation-employed
17 (68.0)
0.1-1.3
0.15
9 (42.9)
0.7-5.0
0.18
Ulcerative colitis
23 (92.0)
0.1-2.9
0.52
19 (90.5)
0.1-3.8
0.74
EIMs- present
3 (12.0)
0.1-1.5
0.19
5 (23.8)
0.3-3.7
0.73
Quality of life+
Digestive symptoms
9 (36.0)
0.7-5.4
0.14
12 (57.1)
2.3-18-5
<0.001
Systemic symptoms
10 (40.0)
0.5-3.4
0.51
15 (71.4)
2.5-21.4
<0.001
Emotional symptoms
10 (40.0)
0.7-4.7
0.20
13 (61.9)
2.1-16.3
<0.001
Social
6 (24.0)
0.5-4.7
0.39
9 (42.9)
1.8-16.2
<0.001
Total
9 (36.0)
0.6-4.6
0.24
13 (61.9)
2.5-20.9
<0.001
(b)
Depression
value
Anxiety
value
Present
Absent
Present
Absent
Mean (S.D)
Mean (S.D)
Age (years)
45.2 (8.2)
40.7 (12.5)
0.04
43.2 (12.2)
41.4 (11.6)
0.52
Level of education (years)
12.9 (3.1)
12.9 (4.2)
0.99
12.4 (3.9)
13.0 (4.0)
0.57
Age of diagnosis (years)
31.7 (10.5)
31.0 (12.7)
0.81
33.6 14.3
30.6 (11.6)
0.31
Illness evolution (years)
13.5 (9.2)
9.6 (6.3)
0.06
9.6 9.3
10.8 (6.6)
0.51
IBD: inflammatory bowel disease; EIMs: extraintestinal manifestations. +The percentages reported are for patients with moderate to severe affections in IBDDQ-32 dimensions. The percentages reported are for patients with moderate to severe affections in IBDQ-32 dimensions.
